# Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin

> **NCT03906916** · PHASE4 · TERMINATED · sponsor: **Fadoi Foundation, Italy** · enrollment: 14 (actual)

## Conditions studied

- Invasive Candidiasis

## Interventions

- **DIAGNOSTIC_TEST:** 1,3-β-D-glucan quantification
- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT03906916
- **Lead sponsor:** Fadoi Foundation, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-18
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-02-01
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The study was interrupted prematurely because of the low rate of recruitment.
- **Last updated:** 2021-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03906916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03906916, "Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03906916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*